Prophylaxis of venous thromboembolism in brain tumor patients.
Thromboembolism is a common problem in patients with brain tumors. Within this population are subpopulations of patients at varying but substantial risk for deep vein thrombosis and pulmonary embolism. Prophylactic strategies can be applied to these various risk groups that will dramatically reduce the incidence of thromboembolism, and these should be applied on a routine basis. The standard prophylactic methods for thromboembolic prophylaxis include mechanical devices (e.g., graduated leg stockings; external pneumatic calf compression) and pharmacological agents (e.g., low dose heparin). In addition, a basic knowledge of low molecular weight heparins and heparinoids is essential because these new agents have a potentially promising role in the prophylaxis of neurological disease in certain patients. The principles concerning the prophylaxis of venous thromboembolic disease in patients with brain tumors are addressed in this review.
Hamilton
M G
MG
Department of Clinical Neuroscience, University of Calgary, Alberta, Canada.
Hull
R D
RD
Pineo
G F
GF
D001932:Brain Neoplasms / Q000150:complications*; D006801:Humans; D015994:Incidence; D011315:Preventive Medicine / Q000379:methods*; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000517:prevention & control; D013923:Thromboembolism / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D013924:Thrombophlebitis / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*